Pre- and paraclinical cooperative trials on testicular cancer. Background and overview of current trials;Prä- und paraklinische verbundstudien beim hodentumor. Hintergründe und aktuelle studienübersicht

Urologe - Ausgabe A

Volumn 46, Issue 9, 2007, Pages 1180-1184

  Dieckmann, K P ^a  

^a ALBERTINEN KRANKENHAUS   (Germany)

Author keywords

Body size; Chemotherapy; Cooperative studies; Down syndrome; Late relapse; Myocardial infarction; Testicular cancer

Indexed keywords

ARTICLE; BODY HEIGHT; BODY SIZE; CANCER CHEMOTHERAPY; CANCER REGISTRY; DISEASE FREE INTERVAL; DOWN SYNDROME; GERMANY; HEART INFARCTION; HUMAN; PROGNOSIS; PROSTATE CANCER; RELAPSE; RISK FACTOR; TESTIS TUMOR;

ANTINEOPLASTIC AGENTS; BODY SIZE; DOWN SYNDROME; GERMANY; HUMANS; MALE; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL INFARCTION; PATIENT CARE TEAM; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SOCIETIES, MEDICAL; STATISTICS AS TOPIC; TESTICULAR NEOPLASMS; TESTIS;

EID: 34648837098     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-007-1399-1     Document Type: Article

References (24)

1. Aass N, Klepp O, Cavallin-Stahl E et al. (1991) Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience. J Clin Oncol 9: 818-826
2. Albers P, Siener R, Kliesch S et al. (2003) Risk factors for relapse in clinical stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol 21: 1505-1512
3. Aparicio J, Germa JR, Del Muro XG et al. (2005) Risk-adapted management for patients with clinical stage I Seminoma: The Second Spanish Germ Cell Cancer Cooperative Group Study. J Clin Oncol 23: 8717-8723
4. Bokemeyer C, Kollmannsberger C, Stenning S et al. (2004) Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials. Br J Cancer 91: 683-687
5. Classen J, Schmidberger H, Meisner C et al. (2004) Para-aortic irradiation for stage I testicular seminoma: results of a prospective study in 675 patients. A trial of the German testicular cancer study group (GTCSG). Br J Cancer 90: 2305-2311
6. Dieckmann KP, Albers P, Classen J et al. (2005) Late relapse of testicular germ cell neoplasms: A descriptive analysis of 122 cases. J Urol 173: 824-829
7. Dieckmann KP, Hartmann JT, Pottek T et al. (2006) Myokardinfarkte während zytostatischer Therapie beim Hodentumor. Urologe (Suppl 1) 45: S88; Abstract V 2.4
8. Dieckmann KP, Kulejewski M, Pichlmeier U, Loy V (2007) Diagnosis of Contralateral Testicular Intraepithelial Neoplasia (TIN) in patients with Testicular Germ Cell Cancer: Systematic two-Site biopsies are more sensitive than a single random biopsy. Eur Urol 51: 175-185
9. Dieckmann KP, Linke J, Pichlmeier U et al. (2007) Spermatogenesis in the contralateral testis of patients with testicular germ cell cancer: histological evaluation of testicular biopsies and a comparison with healthy males. BJU Int 99: 1079-1085
10. Gesellschaft der epidemiologischen Krebsregister in Deutschland, in Zusammenarbeit mit dem Robert Koch Institut (RKI) (Hrsg) (2006) Krebs in Deutschland. 5. Aufl. RKI, Saarbrücken
11. Heidenreich A, Albers P, Hartmann M et al. (2003) Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group. J Urol 169: 1710-1714
12. Heidenreich A, Weissbach L, Höltl W et al. (2001) Organ Sparing Surgery for malignant Germ Cell Tumors of the Testis. J Urol 166: 2161-2165
13. Horwich A, Oliver RT, Wilkinson PM et al. (2000) MTTW. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. Br J Cancer 83: 1623-1629
14. Krege S, Boergermann C, Baschek R et al. (2006) Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG). Ann Oncol 17: 276-280
15. Loehrer PJS, Johnson D, Elson P et al. (1995) Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: an Eastern Cooperative Oncology Group trial. J Clin Oncol 13: 470-476
16. Oliver RT, Mason MD, Mead GM et al. (2005) Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet 366: 293-300
17. Rick O, Bokemeyer C, Beyer J et al. (2001) Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J Clin Oncol 19: 81-88
18. Schmidberger H, Bamberg M, Meisner C et al. (1997) Radiotherapy in stage IIA and IIB testicular seminoma with reduced portals: a prospective multicenter study. Int J Radiat Oncol Biol Phys 39: 321-326
19. Schultz HP, Arends J, Barlebo H et al. (1984) Testicular carcinoma in Denmark 1976-1980. Stage and selected clinical parameters at presentation. Acta Radiol Oncol 23: 249-253
20. Unger G, Wegener G, Günther B (Hrsg) (1996) Hodentumoren in Niedersachsen und Bremen. Kassenärztliche Vereinigung Niedersachsen, Hannover
21. Weissbach L, Boedefeld EA, Horstmann Dubral B (1990) Surgical treatment of stage-I non-seminomatous germ cell testis tumor. Final results of a prospective multicenter trial 1982-1987. Testicular Tumor Study Group. Eur Urol 17: 97-106
22. Weißbach L, Bussar-Maatz R (Hrsg) (1988) Die Diagnostik des Hodentumors und seiner Metastasen. Ergebnisse einer TNM-Validierungsstudie. Karger, Basel
23. Weißbach L, Hildebrand G (Hrsg) (1982) Register und Verbundstudie für Hodentumoren - Bonn. W. Zuckschwerdt Verlag, München
24. Wozniak AJ, Samson MK, Shah NT et al. (1991) A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study. J Clin Oncol 9: 70-76